BAJAJ BROKING

Notification
No new Notification messages
🚨 Trading Holiday 🚨
The NSE and BSE will remain closed for trading and settlement on Friday, April 18, 2025, on account of Good Friday.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
kabra drugs ltd. stock

KABRA DRUGS LTD. Share Price

11.08 0.00 (0.00%)
Apr 15 2025 12:00 AM Pharmaceuticals NSE: KABRADG

KABRA DRUGS LTD. Share Price Update

As of the latest trading session, KABRA DRUGS LTD. share price is currently at 11.08, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 11.08 and 11.08. Over the past year, KABRA DRUGS LTD. has achieved a return of 54.10 %. In the last month alone, the return has been 0.00 %. Read More...

KABRA DRUGS LTD. Performance

Day Range

Low11.08 High11.08
11.08

52 Week Range

Low 7.19 High 11.08
11.08

KABRA DRUGS LTD. Share Price

524322

KABRADG

img img img img
No Data Available

Open Price

11.08

Prev. Close

11.08

Volume (Shares)

102.00

Total traded value

.01

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

KABRA DRUGS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 26.30
PE Ratio (TTM) -14.21
Book Value / Share 10.58
Beta -0.08
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.54

KABRA DRUGS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.54
Net Profit -0.54
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.53
EBITDA -0.54
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.40
Net Profit -0.40
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.39
EBITDA -0.40
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.55
Net Profit -0.55
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.24
EBITDA -0.55
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.37
Net Profit -0.37
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.84
EBITDA -0.37
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit -0.11
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.25
EBITDA -0.11
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.74
Net Profit -0.74
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.68
EBITDA -0.74
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.34
Net Profit -0.34
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.77
EBITDA -0.34
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit -0.19
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.42
EBITDA -0.18
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.18
Net Profit -0.18
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.41
EBITDA -0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.14
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -3.34
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 8.83
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -0.90
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -0.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share -0.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.67
Total Assets 4.57
Total Liabilities 4.57
Total Equity 1.08
Share Outstanding 4388600
Price to Book Ratio -2.15
Return on Assets (%) -16.10
Return on Capital (%) -26.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.70
Total Liabilities 0.70
Total Equity -0.73
Share Outstanding 4388600
Price to Book Ratio -3.34
Return on Assets (%) -48.02
Return on Capital (%) -51.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.72
Total Liabilities 0.72
Total Equity -0.39
Share Outstanding 4388600
Price to Book Ratio -5.06
Return on Assets (%) -25.40
Return on Capital (%) -29.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 1.40
Total Liabilities 1.40
Total Equity -0.20
Share Outstanding 4388600
Price to Book Ratio 0.00
Return on Assets (%) -12.83
Return on Capital (%) -25.99
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 1.41
Total Liabilities 1.41
Total Equity -0.02
Share Outstanding 4388600
Price to Book Ratio -52.33
Return on Assets (%) -4.21
Return on Capital (%) -9.54
Particulars MAR 2024 (Values in Cr)
Net Income -0.73
Cash from Operations -0.20
Cash from Investing 0.00
Cash from Financing 2.87
Net change in Cash 2.66
Free Cash Flow -0.20
Particulars MAR 2023 (Values in Cr)
Net Income -0.33
Cash from Operations -0.35
Cash from Investing 0.00
Cash from Financing 0.35
Net change in Cash 0.00
Free Cash Flow -0.35
Particulars MAR 2022 (Values in Cr)
Net Income -0.18
Cash from Operations -0.13
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.13
Particulars MAR 2021 (Values in Cr)
Net Income -0.18
Cash from Operations -0.24
Cash from Investing 0.00
Cash from Financing 0.24
Net change in Cash 0.00
Free Cash Flow -0.24
Particulars MAR 2020 (Values in Cr)
Net Income -0.05
Cash from Operations -0.04
Cash from Investing 0.06
Cash from Financing -0.01
Net change in Cash 0.00
Free Cash Flow -0.04
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 39.03 20.98 2.13 299.10 34.11 / 77.70
BLISS GVS PHARMA LTD 124.20 16.28 1.29 1308.70 92.25 / 184.95
CIPLA LTD 1481.40 23.98 4.21 119640.40 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 275.45 22.82 2.79 810.68 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2876.65 57.05 29.13 48732.19 1825.05 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 39.03 23.51 6.63 299.10 34.11 / 77.70
AMRUTAJAN HEALTH LTD 671.60 39.37 6.52 1941.64 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8871.70 132.31 32.64 22179.25 5000.00 / 9049.95
BLISS GVS PHARMA LTD 124.20 16.13 1.27 1308.70 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 11.00
  • 26 Days 10.10
  • 10 Days 10.70
  • 50 Days 9.10
  • 12 Days 10.60
  • 100 Days 7.80
  • 20 Days 10.30
  • 200 Days 6.40
11.08
PIVOT
First Resistance 11.08
Second Resistance 11.08
Third Resistance 11.08
First Support 11.08
Second Support 11.08
Third Support 11.08
RSI 0.00
MACD 0.59
Commodity Channel Index (CCI) 117.21
ADX 100.00
Williams % R 0.00

Over 1 Month

down

0.00

Over 3 Months

down

10.13

Over 6 Months

down

21.22

Over 1 Year

down

54.10

Over 3 Years

down

41.51

Over 5 Years

down

25.42

KABRA DRUGS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

KABRA DRUGS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
100.0
Promoter Holdings
0.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Kuniamuthur Nanjappan Anand Public Shareholding 658500.0 6.53
Muralidharan.r Public Shareholding 457000.0 4.53
Chandraprakash Jamnalal Kabra Public Shareholding 400000.0 3.97
Priyam Samir Shah Public Shareholding 350000.0 3.47
Rahul Anantrai Mehta Public Shareholding 206424.0 2.05
Farahan Karim Amalani Public Shareholding 200000.0 1.98
Gladis Menezes Public Shareholding 200000.0 1.98
Miral Hemantbhai Bhoot Public Shareholding 200000.0 1.98
Ranjana Kanda Public Shareholding 200000.0 1.98
Rajendrakumar Sukhraj Jain Public Shareholding 200000.0 1.98
Manjula Vinod Kothari Public Shareholding 146396.0 1.45
Praveen Kumar Saboo Public Shareholding 105000.0 1.04

KABRA DRUGS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About KABRA DRUGS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by KABRA DRUGS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Kabra Drugs Ltd?

Answer Field

The share price of Kabra Drugs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 11.08.

What is the Market Cap of Kabra Drugs Ltd?

Answer Field

The market cap of Kabra Drugs Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 26.30 Cr. as of now.

What is the 52 Week High and Low of Kabra Drugs Ltd?

Answer Field

The 52 Week High and Low of Kabra Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 11.08 and ₹ 7.19.

How to Buy Kabra Drugs Ltd share?

Answer Field

You can trade in Kabra Drugs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Kabra Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 54.10%.

What is the Current Share Price of Kabra Drugs Ltd?

Answer Field

Kabra Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 11.08 as on Apr 15 2025 12:00 AM.

What is the Market Cap of Kabra Drugs Ltd Share?

Answer Field

The market cap of Kabra Drugs Ltd for NSE ₹ 0.0 & for BSE ₹ 26.30 as on Apr 15 2025 12:00 AM.

What is the P/E Ratio of Kabra Drugs Ltd Share?

Answer Field

As on Apr 15 2025 12:00 AM the price-to-earnings (PE) ratio for Kabra Drugs Ltd share is -14.21.

What is the PB ratio of Kabra Drugs Ltd Share?

Answer Field

As on Apr 15 2025 12:00 AM, the price-to-book (PB) ratio for Kabra Drugs Ltd share is 10.58.

How to Buy Kabra Drugs Ltd Share?

Answer Field

You can trade in Kabra Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kabra Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Kabra Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kabra Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9.5 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4400+ Cr MTF Book

icon-with-text
loader